Literature DB >> 24627537

Human rhinovirus infection during naturally occurring COPD exacerbations.

Sîobhán N George1, Davinder S Garcha2, Alexander J Mackay2, Anant R C Patel2, Richa Singh2, Raymond J Sapsford2, Gavin C Donaldson2, Jadwiga A Wedzicha2.   

Abstract

Human rhinovirus (HRV) infection is an important trigger of exacerbations of chronic obstructive pulmonary disease (COPD) but its role in determining exacerbation frequency phenotype or the time-course of HRV infection in naturally occurring exacerbations is unknown. Sputum samples from 77 patients were analysed by real-time quantitative PCR for both HRV (388 samples), and Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis (89 samples). Patients recorded worsening of respiratory symptoms on daily diary cards, from which exacerbations were identified. HRV prevalence and load at exacerbation presentation were significantly higher than in the stable state (prevalence 53.3% versus 17.2%, respectively; p<0.001) but 0% by day 35 post-exacerbation. HRV load was higher in patients with cold symptoms (p=0.046) or sore throats (p=0.006) than those without. 73% of bacterium-negative but HRV-positive exacerbations were bacterium-positive by day 14. Patients with HRV detected at exacerbation had a higher exacerbation frequency (interquartile range) of 3.01 (2.02-5.30) per year compared with patients without HRV (2.51 (2.00-3.51)) (p=0.038). HRV prevalence and load increased at COPD exacerbation, and resolved during recovery. Frequent exacerbators were more likely to experience HRV infection. Secondary bacterial infection is common after HRV infection, and provides a possible mechanism for exacerbation recurrence and a potential target for novel therapies. © ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 24627537     DOI: 10.1183/09031936.00223113

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  65 in total

1.  The Anti-inflammatory Effect of Alpha-1 Antitrypsin in Rhinovirus-infected Human Airway Epithelial Cells.

Authors:  Di Jiang; Reena Berman; Qun Wu; Connor Stevenson; Hong Wei Chu
Journal:  J Clin Cell Immunol       Date:  2016-12-05

2.  Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.

Authors:  Gavin C Donaldson; Martin Law; Beverly Kowlessar; Richa Singh; Simon E Brill; James P Allinson; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2015-10-15       Impact factor: 21.405

Review 3.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

Review 4.  [Rhinoviruses].

Authors:  A Grünewaldt; C Hügel; G G U Rohde
Journal:  Internist (Berl)       Date:  2019-11       Impact factor: 0.743

5.  Emerging biology of persistent mucous cell hyperplasia in COPD.

Authors:  Renat Shaykhiev
Journal:  Thorax       Date:  2018-09-28       Impact factor: 9.139

6.  Exacerbations of Lung Disease in Alpha-1 Antitrypsin Deficiency.

Authors:  Daniel J Smith; Paul R Ellis; Alice M Turner
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

Review 7.  Digging through the Obstruction: Insight into the Epithelial Cell Response to Respiratory Virus Infection in Patients with Cystic Fibrosis.

Authors:  Matthew R Hendricks; Jennifer M Bomberger
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

8.  3-Aryl-1,2,4-oxadiazole Derivatives Active Against Human Rhinovirus.

Authors:  Jinwoo Kim; Jin Soo Shin; Sunjoo Ahn; Soo Bong Han; Young-Sik Jung
Journal:  ACS Med Chem Lett       Date:  2018-04-13       Impact factor: 4.345

Review 9.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

Review 10.  Rhinovirus-Induced Airway Disease: A Model to Understand the Antiviral and Th2 Epithelial Immune Dysregulation in Childhood Asthma.

Authors:  Geovanny F Perez; Carlos E Rodriguez-Martinez; Gustavo Nino
Journal:  J Investig Med       Date:  2015-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.